Back to search results

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

CNS Embryonal Tumor · CNS, Medulloblastoma · Atypical Teratoid Rhabdoid Tumor · Medulloblastoma, Childhood · Medulloblastoma, Group 3 · Medulloblastoma, Group 4 · Pineoblastoma · Neuroblastoma · Embryonal Tumor With Multilayered Rosettes · Embryonal Tumor With Abundant Neuropil and True Rosettes · Ependymoblastoma · Medulloepithelioma · CNS Embryonal Tumor With Rhabdoid Features · CNS Embryonal Tumor, Nos

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Alberta Children's Hospital, Calgary, Alberta, Canada

    Contact: Study coordinator (Oluwatosin Ogunleye) · Oluwatosin.Ogunleye@albertahealthservices.ca
    Contact: Study coordinator (Lucie Lafay-Cousin) · lucie.lafay-cousin@albertahealthservices.ca
    Contact: Principal Investigator (Lucie Lafay-Cousin)

  • BC Children's Hospital, Vancouver, British Columbia, Canada

    Contact: Study coordinator (Sofie Jensen) · sofie.jensen@cw.bc.ca
    Contact: Principal Investigator (George Michaiel)

  • CancerCare Manitoba (CCMB), Winnipeg, Manitoba, Canada

    Contact: Study coordinator (Divya Subburaj, MD) · ctu_web@cancercare.mb.ca · 204-787-4156
    Contact: Principal Investigator (Divya Subburaj)

  • IWK Health Centre, Halifax, Nova Scotia, Canada

    Contact: Study coordinator (Tiffany Rent) · Tiffany.Rent@iwk.nshealth.ca
    Contact: Principal Investigator (Bruce Crooks)

  • McMaster Children's Hospital, Hamilton, Ontario, Canada

    Contact: Study coordinator (Shawde Campbell) · campshaw@HHSC.CA
    Contact: Principal Investigator (Adam Fleming)

  • London Health Sciences Centre, London, Ontario, Canada

    Contact: Study coordinator (Jessica Kuzyk) · jessica.kuzyk@lhsc.on.ca
    Contact: Principal Investigator (Shayna Zelcer)

  • CHU Sainte-Justine, Montreal, Quebec, Canada

    Contact: Study coordinator (Caroline Tra) · caroline.tra.hsj@ssss.gouv.qc.ca
    Contact: Principal Investigator (Sebastien Perreault)

  • Montreal Children's Hospital (McGill), Montreal, Quebec, Canada

    Contact: Study coordinator (Poshia Boateng) · poshia.boateng@muhc.mcgill.ca
    Contact: Principal Investigator (Christina Coleman)

  • CHU de Québec-Université Laval, Québec, Quebec, Canada

    Contact: Study coordinator (Panagiota Giannakouros) · Panagiota.Giannak@crchudequebec.ulaval.ca
    Contact: Principal Investigator (Samuele Renzi)

  • Centre hospitalier universitaire de Sherbrooke (CHUS), Sherbrooke, Quebec, Canada

    Contact: Study coordinator (Alexis Gonneaud) · alexis.gonneaud.ciussse-chus@ssss.gouv.qc.ca
    Contact: Principal Investigator (Stephanie Vairy)

  • Stollery Children's Hospital, Edmonton, Canada

    Contact: Study coordinator (Guru Piragasam) · Guru.Piragasam@albertahealthservices.ca
    Contact: Principal Investigator (Liana Nobre)

  • The Hospital for Sick Children, Toronto, Canada

    Contact: Study coordinator (Grace Silver) · grace.silver@sickkids.ca
    Contact: Principal Investigator (Anthony Liu)
Study leads

  • Sylvia Cheng

    Study Chair

    BC Cancer Centre

  • Annie Huang

    Study Chair

    The Hospital for Sick Children

  • Lucie Lafay-Cousin

    Study Chair

    Alberta Children's Hospital

View source on ClinicalTrials.gov(opens in a new tab)